CrowdStrike President's 10b5-1 Sale of 20,000 Shares at $500

Rhea-AI Filing Summary

Michael Sentonas, President of CrowdStrike Holdings, Inc. (CRWD), reported the sale of 20,000 shares of Class A common stock on 10/01/2025 at a reported price of $500 per share. After the sale he beneficially owns 379,116 shares, which includes shares to be issued from the vesting of one or more restricted stock units (RSUs). The Form 4 also notes the sale was made pursuant to a 10b5-1 trading plan adopted on June 24, 2025.

The filing is signed on behalf of Mr. Sentonas by an attorney-in-fact on 10/03/2025. No derivative transactions are reported on this Form 4.

Positive

• Sale executed under a 10b5-1 plan adopted on June 24, 2025, which helps demonstrate a pre‑planned transaction
• No derivative activity reported on this Form 4, limiting complexity of disclosed insider positions

Negative

• Insider sold 20,000 shares, reducing direct holdings to 379,116 shares
• Portion of holdings are unissued RSUs, indicating part of the beneficial ownership is contingent on future vesting

Insights

Corporate Insider / Governance Analyst

Insider sold 20,000 shares under a 10b5-1 plan; remaining stake listed as 379,116 shares.

This transaction is a planned sale under a 10b5-1 arrangement adopted on June 24, 2025, which provides an affirmative defense to insider trading allegations when properly established. The sale on 10/01/2025 of 20,000 shares at $500 per share reduced his directly reported holdings to 379,116 shares.

Because the filing states some holdings "include" shares from vesting RSUs, part of the beneficial ownership reflects awards not yet settled. No options, warrants, or other derivative transactions appear on this Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sentonas Michael

(Last) (First) (Middle)

C/O CROWDSTRIKE HOLDINGS, INC.

206 E. 9TH STREET, SUITE 1400

(Street)

AUSTIN TX 78701

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CrowdStrike Holdings, Inc. [ CRWD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock	10/01/2025		S		20,000(1)	D	$500	379,116(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes shares sold pursuant to a 10b5-1 plan adopted on June 24, 2025.

2. Includes shares to be issued in connection with the vesting of one or more restricted stock units (RSUs).

	/s/ Remie Solano, Attorney-in-Fact	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Michael Sentonas report on Form 4 for CRWD?

The filing reports a sale of 20,000 shares of Class A common stock on 10/01/2025 at a price of $500 per share; post-transaction beneficial ownership is 379,116 shares.

Was the sale part of a trading plan?

Yes. The sale was made pursuant to a 10b5-1 plan adopted on June 24, 2025, as disclosed in the Form 4.

Does the Form 4 show any option or derivative transactions for Mr. Sentonas?

No. Table II (derivative securities) contains no reported transactions; only the non‑derivative sale of shares is disclosed.

Do the reported holdings include future awards?

Yes. The filing states the 379,116 shares include shares to be issued upon vesting of one or more restricted stock units (RSUs).

Who signed the Form 4?

The Form 4 is signed by Remie Solano, Attorney-in-Fact on behalf of Michael Sentonas, dated 10/03/2025.